The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Sulfonylurea Inadequacy
Abstract
OBJECTIVE—To evaluate the efficacy of the addition of insulin when maximal sulfonylurea therapy is inadequate in individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS—Glycemic control, hypoglycemia, and body weight were monitored over 6 years in 826 patients with newly diagnosed type 2 diabetes in 8 of 23 U.K. Prospective Diabetes Study (UKPDS) centers that used a modified protocol. Patients were randomly allocated to a conventional glucose control policy, primarily with diet (n = 242) or an intensive policy with insulin alone (n = 245), as in the main study. However, for patients randomized to an intensive policy with sulfonylurea (n = 339), insulin was added automatically if the fasting plasma glucose remained >108 mg/dl (6.0 mmol/l) despite maximal sulfonylurea doses. RESULTS—Over 6 years, ∼53% of patients allocated to treatment with sulfonylurea required additional insulin therapy. Median HbA1c in the sulfonylurea ± insulin group was significantly lower (6.6%, interquartile range [IQR] 6.0–7.6) than in the group taking insulin alone (7.1%, IQR 6.2–8.0; P = 0.0066), and significantly more patients in the sulfonylurea ± insulin group had an HbA1c <7% (47 vs. 35%, respectively; P = 0.011). Weight gain was similar in the intensive therapy groups, but major hypoglycemia occurred less frequently over all in the sulfonylurea (± insulin) group compared with the insulin alone group (1.6 vs. 3.2% per annum, respectively; P = 0.017). CONCLUSIONS—Early addition of insulin when maximal sulfonylurea therapy is inadequate can significantly improve glycemic control without promoting increased hypoglycemia or weight gain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
UK prospective diabetes study (UKPDS): VIII. Study design, progress and performance
UK Prospective Diabetes Study Group (1991) · Diabetologia · doi:10.1007/bf00400195 · Cited by 543
Turner, R., Cull, C., Holman, R., & United Kingdom Prospective Diabetes Study Group (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00011 · Cited by 465
Self-citationRiddle, M. C., Schneider, J., & The Glimepiride Combination Group (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1052 · Cited by 154
Efficacy of Insulin and Sulfonylurea Combination Therapy in Type II Diabetes
Johnson, J. L. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030049007 · Cited by 145
UK Prospective Diabetes Study Group (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb02032.x · Cited by 118
Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM
shank, M. L., Prato, S. D., & DeFronzo, R. A. (1995) · Diabetes · doi:10.2337/diab.44.2.165 · Cited by 91
Manley, S. E., Meyer, L., Neil, H., Ross, I. S., Turner, R. C., & Holman, R. R. (1994) · Diabetic Medicine · Cited by 86
Self-citationSulphonylurea Failure in Type 2 Diabetes: Treatment with a Basal Insulin Supplement
Holman, R. R., Steemson, J., & Turner, R. C. (1987) · Diabetic Medicine · doi:10.1111/j.1464-5491.1987.tb00909.x · Cited by 72
Self-citationA Practical Guide to Basal and Prandial Insulin Therapy
Holman, R. R., & Turner, R. C. (1985) · Diabetic Medicine · doi:10.1111/j.1464-5491.1985.tb00592.x · Cited by 54
Self-citationJOHNSON, J. L. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.3.259 · Cited by 29
Research works printed but not linked: 1
- Turner RC, Holman RR, Matthews DR: Sulphonylurea failure and inadequacy: “non-insulin diabetes mellitus”. In Proceedings of the 13th IDF Conference, Hamilton Island, Australia, 26–28 1988. Cameron D, Colagiuri S, Heding L, Kuhl C, Ma A, Mortimer R, Eds. Causeway Bay, Hong Kong, Excerpta Medica Asia, 1989
Cited by
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Self-citationRiddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 878
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Holman, R. R., Thorne, K. I., Farmer, A. J., Davies, M. J., Keenan, J. F., Paul, S., & Levy, J. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa075392 · Cited by 710
Self-citation
Metadata
- Authors
- Wright, A., Burden, A. C. F., Paisey, R. B., Cull, C. A., Holman, R. R., & for the U.K. Prospective Diabetes Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-02-01
- Volume
- 25
- Issue
- 2
- Pages
- 330-336
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1996441843
- Cited by
- 556
- References
- 15
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Update notices
- correction (2002-07-01)
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.